Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Pieper

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|March 1, 1996
Evolving role of calcium channel blockers in heart failureJ A Pieper
Pharmacotherapy|September 19, 2001
Management of coronary heart disease risk factors and progression with calcium channel blockersJ A Pieper
Pharmacotherapy|March 1, 1997
Calcium channel blockers: the present and the futureJ A Pieper
Pharmacotherapy|September 19, 2001
Pharmacologic interventions for coronary artery disease and risk factors. IntroductionJ A Pieper
Clinical Pharmacokinetics|May 23, 2001
Clinical pharmacokinetics of fluvastatinC D Scripture, J A Pieper
European Journal of Clinical Pharmacology|January 1, 1987
Gallopamil binding to human serum proteinsD R Rutledge, J A Pieper
Journal of Chromatographic Science|September 1, 1988
Determination of verapamil and its primary metabolites in serum by ion-pair adsorption high-performance liquid chromatographyJ A Pieper, D R Rutledge
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Effects of chronic phenobarbital on verapamil disposition in humansD R Rutledge, J A Pieper, D M Mirvis
Chest|July 1, 1991
Inhaled verapamil-induced bronchoconstriction in mild asthmaE Harman, M Hill, J A Pieper, et al.
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Diltiazem: a review of its clinical efficacy and useT A Tartaglione, C J Pepine, J A Pieper
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|March 1, 1996
Evolving role of calcium channel blockers in heart failureJ A Pieper
Pharmacotherapy|September 19, 2001
Management of coronary heart disease risk factors and progression with calcium channel blockersJ A Pieper
Pharmacotherapy|March 1, 1997
Calcium channel blockers: the present and the futureJ A Pieper
Pharmacotherapy|September 19, 2001
Pharmacologic interventions for coronary artery disease and risk factors. IntroductionJ A Pieper
Clinical Pharmacokinetics|May 23, 2001
Clinical pharmacokinetics of fluvastatinC D Scripture, J A Pieper
European Journal of Clinical Pharmacology|January 1, 1987
Gallopamil binding to human serum proteinsD R Rutledge, J A Pieper
Journal of Chromatographic Science|September 1, 1988
Determination of verapamil and its primary metabolites in serum by ion-pair adsorption high-performance liquid chromatographyJ A Pieper, D R Rutledge
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Effects of chronic phenobarbital on verapamil disposition in humansD R Rutledge, J A Pieper, D M Mirvis
Chest|July 1, 1991
Inhaled verapamil-induced bronchoconstriction in mild asthmaE Harman, M Hill, J A Pieper, et al.
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Diltiazem: a review of its clinical efficacy and useT A Tartaglione, C J Pepine, J A Pieper
Pageof 5